摘要
目的:为完善国家原研药与仿制药管理工作提供科学参考。方法:根据某省药品招标采购中心数据库的数据,分析该省原研药与仿制药的价格差异与市场份额。结果:该省198个样本药品中,原研药与仿制药的价格差异倍数的均值为3.6倍,高于《药品政府定价办法》规定的差价率。结论:我国原研药与仿制药的价格差异高于国家规定。
Objective:To provide scientific reference for the country's price management of brand-name drugs and generics.Methods:We analyzed price comparison and market share between brand-name drugs and generics in a province with the data from the database of medicine bidding and purchase center in the province.Results:The average price ratio of the 198 samples between brand-name drugs and generics was 3.6 in the province.This was higher than the price difference rate as required by the Governmental Pricing Method for the Pharmaceuticals in China.Conclusion:The price difference between brand-name drugs and generics is bigger than the one the government required.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2012年第24期2853-2856,2874,共5页
Chinese Journal of New Drugs
关键词
原研药
仿制药
价格差异
市场份额
brand-name drugs
generics
price difference
market share